- (2014) Volume 15, Issue 3
Whitney O Lane*, Rex C Bentley, Herbert I Hurwitz, Leigh A Howard, Thomas J Polascik, Mark R Anderson, Dan G Blazer
Duke University School of Medicine, Duke University Medical Center, Durham, USA
Received April 14, 2014 – Accepted May 02, 2014
Context Metastases from ampullary malignancies are common, but spread to the testicle and paratesticular tissue is exceedingly rare with only 2 reported cases in the literature. Case Report We report a case of a 70 year-old male with a history of ampullary adenocarcinoma status post pancreaticoduodenectomy who presented with a symptomatic right-sided hydrocele. Subsequent pathology revealed metastatic ampullary adenocarcinoma. Conclusions Metastasis to the testicle and paratesticular tissue from ampullary malignancies is rare, but must be considered in the evaluation of scrotal masses in patients with a history of ampullary malignancy.
Pancreatic Neoplasms; Pancreaticojejunostomy; Testicular Hydrocele; Testicular Neoplasms
Ampullary malignancies have a higher rate of resectability and a more favorable prognostic outcome when compared to other periampullary tumors [1]. Despite this, 30% of patients with ampullary malignancies will have positive lymph nodes status at the time of resection and 50% of these patients will recur, most commonly locoregionally or with liver metastasis [2-4]. Metastasis to the testis and paratesticular tissue is rare with only 2 cases reported [5, 6]. Of those reports, only one case presented with a testicular mass as the initial site of treatment failure following resection [6]. We report a case of metastatic ampullary adenocarcinoma following pancreaticoduodenectomy with a hydrocele as the initial presentation of metastatic spread.
An A 70-year-old male originally presented with abdominal pain, chills and was found to have a total bilirubin of 7 and alkaline phosphatase of 770. He subsequently underwent endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement and brushings. Pathology revealed atypical ductal cells suspicious for adenocarcinoma. At that time, Ca 19-9 was found to be elevated to 561 U/ml (reference range: <40U/ ml). Subsequently, the patient underwent Endoscopic Ultrasound (EUS) and Computed Tomography (CT) scan, both revealing dilatation of the biliary tree, but no discrete pancreatic, ampullary, or biliary mass was identified.
Due to concern for periampullary malignancy, the patient underwent a pancreaticoduodenectomy. Pathology revealed an ampullary adenocarcinoma with negative surgical margins and 1/9 positive lymph nodes (Figure 1). He subsequently underwent 5 weeks of adjuvant chemoradiation with capecitabine and a total of 4500cGy of radiation therapy, followed by 4 months of adjuvant gemcitabine therapy alone. Following completion of adjuvant therapy, he was clinically well, with no evidence of recurrent disease.
At a routine follow-up eighteen months after resection, his CA 19-9 was elevated to 249 U/ml (reference range: <40 U/ml). A CT scan at that time showed no radiographic evidence of metastatic disease and given that the patient was asymptomatic and clinically stable, it was determined that he should continue with routine surveillance.
Twenty-one months following pancreaticoduodenectomy, he was evaluated in clinic for a symptomatic right-sided groin mass and a CT scan showed free fluid in the right inguinal canal (Figure 2). He was subsequently taken to the OR and underwent outpatient right-sided hydrocele repair and excision of a non-communicating loculated cyst of the spermatic cord. Postoperatively, he recovered uneventfully. Surprisingly, despite no gross evidence of metastatic disease in the sac, pathology revealed metastatic moderately differentiated adenocarcinoma consistent with a pancreaticobiliary primary (Figure 3, 4, 5).
Figure 5. Immunohistochemical stain for CA19-9 is strongly positive in the tumor cells in the hydrocele sac, brown DAB (3,3’-diaminobenzidine tetrahydrochloride)chromogen (100X original magnification). The tumor cells were also positive for CDX-2, villin, and cytokeratin 7; they were negative for cytokeratin 20 and calretinin (not shown).
One month following the hydrocele repair, a restaging CT scan revealed no definite peritoneal nodularity, but repeat CA 19-9 was 1387 U/ml(reference range: <40 U/ml). Given the concern for occult peritoneal carcinomatosis, the patient was started on gemcitabine single agent therapy.
Metastatic ampullary malignancies to the testicle and paratesticular tissue are extremely rare, with only several additional cases of periampullary carcinoma with spread to the testicle or paratesticular tissues. Previous case reports have suggested that most cases are discovered as the first presentation of underlying malignancy or concurrently with the pancreatic primary. This case is unique as it is only the second reported case of metastatic spread presenting as a testicular mass following surgical resection.
Multiple theories of metastasis to the testicle and paratesticular tissues have been proposed, including retrograde venous extension, arterial embolization, retrograde lymphatic extension, transperitoneal seeding, and direct invasion [7, 8]. As there was evidence of lymphatic involvement at the time of the initial resection, the suspected route of tumor spread in this case is either lymphatic or direct transperitoneal seeding from peritoneal carcinomatosis.
Although metastasis to the testicle and paratesticular tissue from an ampullary primary is uncommon, it should certainly be considered in the evaluation of a scrotal mass in patients with a history of periampullary malignancy. Unfortunately, as in this case, patients with metastatic periampullary malignancies have a poor prognosis. The median survival in patients receiving chemotherapy is 6 months, while those with untreated disease have a median survival of 2-3 months [9].
Authors declare that they have no conflict of interest to disclose.